ATS 2017 International Conference - Mobile

C101 IPF: CLINICAL STUDIES, THERAPEUTICS, AND MORE II

Tuesday

May

23

2:15 PM

4:15 PM

Type : Poster Discussion Session

Speaker(s)

Presentation(s)

609 Identification of Potential Bi...
05-23-2017 2:15 PM - 4:15 PM

622 Time-to-Event Analysis of Comm...
05-23-2017 2:15 PM - 4:15 PM

619 Evidence of Recent Positive Se...
05-23-2017 2:15 PM - 4:15 PM

602 Accuracy and Reliability of Re...
05-23-2017 2:15 PM - 4:15 PM

606 In Vivo Endobronchial Optical ...
05-23-2017 2:15 PM - 4:15 PM

621 The Effect of N-Acetylcysteine...
05-23-2017 2:15 PM - 4:15 PM

610 Bronchoalveolar Lavage Fluid C...
05-23-2017 2:15 PM - 4:15 PM

603 Real World Experience with Nin...
05-23-2017 2:15 PM - 4:15 PM

623 Plasma Biomarkers of Diffuse P...
05-23-2017 2:15 PM - 4:15 PM

605 The Persistence of Pro-Inflamm...
05-23-2017 2:15 PM - 4:15 PM

616 Prospective Validation of a Ge...
05-23-2017 2:15 PM - 4:15 PM

613 Basal and Serial Plasma Biomar...
05-23-2017 2:15 PM - 4:15 PM

617 Idiopathic Pulmonary Fibrosis ...
05-23-2017 2:15 PM - 4:15 PM

614 The PROFILE (Prospective Obser...
05-23-2017 2:15 PM - 4:15 PM

615 CYFRA-21-1 as a Biomarker with...
05-23-2017 2:15 PM - 4:15 PM

608 Analytical Performance of Envi...
05-23-2017 2:15 PM - 4:15 PM

620 PrepABEL: A Bioinformatic Tool...
05-23-2017 2:15 PM - 4:15 PM

611 Nintedanib Attenuates Lung Fun...
05-23-2017 2:15 PM - 4:15 PM

612 Repeat Low Doses of Bleomycin ...
05-23-2017 2:15 PM - 4:15 PM

624 Generation of Mouse Lung Epith...
05-23-2017 2:15 PM - 4:15 PM

604 Improving Disease-Related Educ...
05-23-2017 2:15 PM - 4:15 PM

601 Appropriateness of Prescribing...
05-23-2017 2:15 PM - 4:15 PM

607 Change in CT-Derived Fibrosis ...
05-23-2017 2:15 PM - 4:15 PM

618 The Global Idiopathic Pulmonar...
05-23-2017 2:15 PM - 4:15 PM

625 Patient-Reported Symptoms of G...
05-23-2017 2:15 PM - 4:15 PM